Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP
Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP

Coronavirus: US Food and Drug Administration issues warning against Trump-promoted treatment

  • Citing risk of heart issues, officials caution against use of hydroxychloroquine outside hospitals and clinical trials
  • US president has championed the malaria drug as a ‘game changer’ in Covid-19 fight despite lack of evidence of its effectiveness

Topic |   Coronavirus pandemic
Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP
Pharmaceutical supply chain experts reported shortages within hours of US President Donald Trump’s initial endorsement of hydroxychloroquine in March. Photo: The Citizens' Voice via AP
READ FULL ARTICLE